Dimiter S Dimitrov

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

Yang Feng, Boro Dropulic, Marianna Sabatino, 2017, Nature Medicine.

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

D. Dimitrov, T. Ying, Wei-zao Chen, 2013, Expert opinion on biological therapy.

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

Wayne A Hendrickson, Peter D Kwong, Joseph Sodroski, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Therapeutic Antibodies: Current State and Future Trends – Is a Paradigm Change Coming Soon?

D. Dimitrov, J. Marks, James D Marks, 2008, Methods in molecular biology.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

David C Montefiori, Susan Zolla-Pazner, Nelson L Michael, 2008, Virology.

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.

Yang Feng, Michel Sadelain, Prasad S Adusumilli, 2016, The Journal of clinical investigation.

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Lin-Fa Wang, C. Broder, D. Dimitrov, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function

Yang Feng, Xiaodong Xiao, D. Dimitrov, 2006, Molecular Cancer Therapeutics.

Cancer treatment by telomerase inhibitors: predictions by a kinetic model.

C. Harley, D. Dimitrov, I. Sidorov, 2003, Mathematical biosciences.

The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization

Ponraj Prabakaran, Xiaodong Xiao, D. Dimitrov, 2005, Virology Journal.